Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Membrane Antigen (PSMA) Expression”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Very early researchActive Not RecruitingNCT05683964
What this trial is testing

Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Who this might be right for
Prostate AdenocarcinomaProstate CancerMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Beth Israel Deaconess Medical Center 9
Early research (Phase 1)Looking for participantsNCT06217822
What this trial is testing

First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Advanced Metastatic Castration-resistant Prostate CancerProstate Specific Membrane Antigen (PSMA) Expression
Bayer 198
Not applicableStudy completedNCT05109884
What this trial is testing

Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder Cancer

Who this might be right for
Prostate Cancer
Medical University of Vienna 10
Not applicableUnknownNCT03876912
What this trial is testing

The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Turku University Hospital 35
Not applicableStudy completedNCT05522257
What this trial is testing

PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

Who this might be right for
Sarcoma,Soft TissueUrothelial Carcinoma
Leiden University Medical Center 25
Testing effectiveness (Phase 2)UnknownNCT05900973
What this trial is testing

Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
D'Or Institute for Research and Education 19